Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus
Amilcar L. Morales; Luz Liriano‐Ward; Amber Tierney; Michelle Sang; Alexander Lalos; Mohamed Hassan; Vinay Nair; Thomas Schiano; Rohit Satoskar; Coleman Smith
Author Information: Transplant Hepatology Service
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.